Marietta Charakida

Dr. Marietta Charakida


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2009 in JAMA
Verified
Journal Article
Open access
PDF file
MCMarietta Charakida
Marietta Charakida
CBChristian Besler
Christian Besler
JBJoana R. Batuca
Joana R. Batuca
SSShirish Sangle
Shirish Sangle
SMSusanna Marques
Susanna Marques
JDJohn E. Deanfield
John E. Deanfield
The antiphospholipid syndrome is an autoimmune disorder characterized by increased levels of circulating antiphospholipid antibodies (aPL), increased thrombotic tendency, and pregnancy morbidity.1,2 Although advances in the treatment and follow-up of individuals with positive aPL have markedly reduced the occurrence of thrombotic events, it has become increasingly recognized that accelerated atherosclerosis is an additional problem in patients with aPL, as in other rheumatic diseases.

1 December 2012 in JACC
Verified
Journal Article
Closed access
MCMarietta Charakida
Marietta Charakida
AJAlexander Jones
Alexander Jones
EFEmanuela Falaschetti
Emanuela Falaschetti
TKTauseef Khan
Tauseef Khan
NFNicholas Finer
Nicholas Finer
JDJohn E. Deanfield
John E. Deanfield

1 August 2014 in The Lancet Diabetes & Endocrinology
Verified
Journal Article
Open access
MCMarietta Charakida
Marietta Charakida
TKTauseef Khan
Tauseef Khan
WJWilliam Johnson
William Johnson
NFNick Finer
Nick Finer
JWJohn Woodside
John Woodside
JDJohn Deanfield
John Deanfield
Excess body fat is associated with an increase in risk of type 2 diabetes and hypertension in adulthood and these risks can adversely affect progression of arterial disease. We aimed to assess the impact of lifelong patterns of adiposity on cardiovascular risk factors and carotid intima media thickness (cIMT) in later life in participants in the 1946 British birth cohort study. The National Survey of Health and Development Study was a nationally representative sample of 5362 singleton births to married parents in England, Scotland, and Wales, stratified by social class, during 1 week in March 1946. Our present study is based on the 60% of participants still alive and with a known present address in England, Scotland, or Wales who attended a clinic assessment after invitation aged 60-64 years. We included participants with lifetime adiposity measures, cardiovascular risk factors, and cIMT measured at 60-64 years. Participants were classified as normal weight or overweight or obese at each age (36, 43, 53, and 60-64 years) in adulthood, and childhood overweight was defined. Patterns of BMI change were identified and we used BMI to define adiposity status. We used multivariable linear regression to establish the cross-sectional association of BMI category at age 60-64 years with cIMT, adjusted for various confounders. We included 1273 (45%) of 2856 participants eligible in 2006-10 (at age 60-64 years) in this study. Compared with normal weight, overweight and obesity were associated with higher cIMT (0·029 mm, 95% CI 0·014-0·043) and systolic blood pressure (7·95 mm Hg, 5·86-10·0). Increased cIMT, systolic blood pressure, leptin, prevalence of diabetes, and reduced adiponectin were all associated with duration of exposure to adult adiposity (p<0·0001 for all). We noted little additional effect of childhood overweight. Individuals who dropped a BMI category in adulthood had lower cIMT (-0·034 mm, -0·056 to -0·013) and leptin concentrations (-0·4 ng/mL, -0·47 to -0·32), even when this change was not maintained, than did those who never lost weight. Longer exposure to high adiposity in adulthood had a cumulative adverse effect on cardiovascular phenotype in later life. Reductions in BMI category, even if not sustained, were associated with decreases in cIMT and improvements in cardiovascular risk-factor profile, suggesting that weight loss, at any age in adulthood, is worthwhile because it might result in long-term cardiovascular benefit. Medical Research Council and the British Heart Foundation.

1 July 2021 in Circulation: Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
DLDavid Lloyd
David Lloyd
MPMilou P.M. van Poppel
Milou P.M. van Poppel
KPKuberan Pushparajah
Kuberan Pushparajah
TVTrisha V. Vigneswaran
Trisha V. Vigneswaran
VZVita Zidere
Vita Zidere
RRReza Razavi
Reza Razavi
Background: Identifying fetuses at risk of severe neonatal coarctation of the aorta (CoA) can be lifesaving but is notoriously challenging in clinical practice with a high rate of false positives. Novel fetal 3-dimensional and phase-contrast magnetic resonance imaging (MRI) offers an unprecedented means of assessing the human fetal cardiovascular system before birth. We performed detailed MRI assessment of fetal vascular morphology and flows in a cohort of fetuses with suspected CoA, correlated with the need for postnatal intervention. Methods: Women carrying a fetus with suspected CoA on echocardiography were referred for MRI assessment between 26 and 36 weeks of gestation, including high-resolution motion-corrected 3-dimensional volumes of the fetal heart and phase-contrast flow sequences gated with metric optimized gating. The relationship between aortic geometry and vascular flows was then analyzed and compared with postnatal outcome. Results: Seventy-two patients (51 with suspected fetal CoA and 21 healthy controls) underwent fetal MRI with motion-corrected 3-dimensional vascular reconstructions. Vascular flow measurements from phase-contrast sequences were available in 53 patients. In the CoA group, 25 of 51 (49%) required surgical repair of coarctation after birth; the remaining 26 of 51 (51%) were discharged without neonatal intervention. Reduced blood flow in the fetal ascending aorta and at the aortic isthmus was associated with increasing angulation ( P =0.005) and proximal displacement ( P =0.006) of the isthmus and was seen in both true positive and false positive cases. A multivariate logistic regression model including aortic flow and isthmal displacement explained 78% of the variation in outcome and correctly predicted the need for intervention in 93% of cases. Conclusions: Reduced blood flow though the left heart is associated with important configurational changes at the aortic isthmus in fetal life, predisposing to CoA when the arterial duct closes after birth. Novel fetal MRI techniques may have a role in both understanding and accurately predicting severe neonatal CoA.

28 August 2018 in European Heart Journal
Verified
Journal Article
Open access
PDF file
MCMarietta Charakida
Marietta Charakida
GGGeorge Georgiopoulos
George Georgiopoulos
FDFrida Dangardt
Frida Dangardt
SCScott T Chiesa
Scott T Chiesa
AHAlun D. Hughes
Alun D. Hughes
JDJohn E Deanfield
John E Deanfield
To determine the impact of smoking and alcohol exposure during adolescence on arterial stiffness at 17 years. Smoking and alcohol use were assessed by questionnaires at 13, 15, and 17 years in 1266 participants (425 males and 841 females) from the ALSPAC study. Smoking status (smokers and non-smoker) and intensity (‘high’ ≥100, ‘moderate’ 20–99, and ‘low or never’ <20 cigarettes in lifetime) were ascertained. Participants were classified by frequency (low or high) and intensity of drinking [light (LI 10 drinks on a typical drinking day)]. Carotid to femoral pulse wave velocity (PWV) was assessed at 17 years [mean ± standard deviation and/or mean difference (95% confidence intervals)]. Current smokers had higher PWV compared with non-smokers (P = 0.003). Higher smoking exposure was associated with higher PWV compared with non-smokers [5.81 ± 0.725 vs. 5.71 ± 0.677 m/s, mean adjusted difference 0.211 (0.087–0.334) m/s, P = 0.001]. Participants who stopped smoking had similar PWV to never smokers (P = 0.160). High-intensity drinkers had increased PWV [HI 5.85 ± 0.8 vs. LI 5.67 ± 0.604 m/s, mean adjusted difference 0.266 (0.055–0.476) m/s, P = 0.013]. There was an additive effect of smoking intensity and alcohol intensity, so that ‘high’ smokers who were also HI drinkers had higher PWV compared with never-smokers and LI drinkers [mean adjusted increase 0.603 (0.229–0.978) m/s, P = 0.002]. Smoking exposure even at low levels and intensity of alcohol use were associated individually and together with increased arterial stiffness. Public health strategies need to prevent adoption of these habits in adolescence to preserve or restore arterial health.

1 November 2009 in Antiviral Therapy
Verified
Journal Article
Closed access
MCMarietta Charakida
Marietta Charakida
SLStavros P Loukogeorgakis
Stavros P Loukogeorgakis
MOMichael I Okorie
Michael I Okorie
SMStefano Masi
Stefano Masi
JHJulian P Halcox
Julian P Halcox
NKNigel J Klein
Nigel J Klein
Background: Recent evidence suggests that both the HIV virus and antiretroviral therapy (ART) are associated with premature atherosclerosis in adults. Increased arterial stiffness as assessed by pulse wave velocity (PWV) has been associated with adverse cardiovascular outcome in adults. The relationship between HIV infection and treatment and arterial stiffness has not been evaluated in children. Methods: We studied 83 HIV-infected children with a mean ±sd age of 11.0 ±3.1 years and 59 controls aged 12.2 ±2.8 years. Among the HIV-infected children, 48 were receiving ART (23 including a protease inhibitor). Arterial stiffness was assessed non-invasively by carotid–radial PWV. Disease severity was defined according to the CDC classification. Results: PWV was significantly increased in HIV-infected children compared with controls ( P<0.05). A significant association between age and PWV was noted in HIV-infected children but not in controls. HIV-infected children receiving ART had significantly increased total cholesterol levels and PWV compared with non-treated children ( P<0.001 and P<0.05, respectively). CDC stage was greater in ART-treated compared with non-treated HIV- infected children ( P<0.001). No differences in other cardiovascular risk factors were noted in the two groups. After multivariable analysis, ART, systolic blood pressure, disease severity and total cholesterol remained independent predictors of PWV. Conclusions: HIV-infected children have increased arterial stiffness compared with healthy children. These changes were more pronounced with increasing age in HIV-infected children particularly in those who were receiving ART.